Related Experiment Video
Updated: May 26, 2026
08:34
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Telomere dysfunction and its role in haematological cancer
Ceri H Jones1, Chris Pepper, Duncan M Baird
1Department of Haematology,School of Medicine, Cardiff University, Cardiff, UK.
British Journal of Haematology
|January 12, 2012
Summary
Telomere dysfunction, driven by shortening and fusion, is a key factor in genomic instability and progression for solid tumours and blood cancers. This dysfunction offers prognostic insights and potential therapeutic targets for malignancies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Telomere dysfunction is implicated in genomic instability and progression of solid tumours.
- This dysfunction involves telomere shortening, fusion, and large-scale genomic rearrangements.
Purpose of the Study:
- To investigate the role of telomere dysfunction in haematological malignancies.
- To explore telomere length as a prognostic marker and therapeutic target in cancer.
Main Methods:
- Analysis of telomere length and dysfunction in human tumour samples and mouse models.
- Correlation of telomere characteristics with genomic complexity and disease progression.
Main Results:
- Evidence suggests telomere dysfunction is also crucial in haematological malignancies.
- Extreme telomere shortening, dysfunction, and fusion correlate with increased genomic complexity in these cancers.
- Telomere length provides clinically useful prognostic information.
Conclusions:
- Telomere dysfunction is a significant factor in both solid tumours and haematological malignancies.
- Telomeres serve as a potential prognostic tool and therapeutic target for cancer treatment.
Related Concept Videos
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...